Cogent Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $208,130,000.

Profit Margin

Cogent Biosciences, Inc. (NASDAQ:COGT): Profit margin
2015 2.98M -6.59M -220.76%
2016 6.35M -18.12M -285.19%
2017 8.36M -25.49M -304.93%
2018 9.73M -34.53M -354.76%
2019 22.49M -30.27M -134.55%
2020 7.87M -66.45M -844.25%
2021 0 -71.80M
2022 0 -132.64M
2023 0 -192.41M

COGT Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0007.87M22.49M9.73M8.36M6.35M2.98M
Cost of revenue
3.58M5.87M147K25.73K43.70K0000
Gross profit
-3.58M-5.87M-147K7.84M22.45M9.73M8.36M6.35M2.98M
Operating exp.
Research and development
173.75M121.62M55.91M72.64M43.70M38.28M29.83M21.99M6.85M
Selling and marketing
000000000
Total operating expenses
208.13M147.83M75.55M90.07M54.67M45.73M34.51M25.42M9.57M
Operating income
-208.13M-147.83M-75.55M-82.19M-32.17M-36.00M-26.15M-19.07M-6.59M
Other income (expenses), net
15.72M7.59M3.27M7.39M345K320K660K681K0
Income before tax
-192.41M-140.24M-72.27M-74.80M-31.83M-34.53M-25.49M-18.12M-6.59M
Income tax expense
0-7.59M-467K-8.35M-1.56M1.47M-386K-265K0
Net income
-192.41M-132.64M-71.80M-66.45M-30.27M-34.53M-25.49M-18.12M-6.59M
Earnings per share
Basic EPS
-2.42-2.26-1.85-6-3.97-5.55-3.45-3.1-1.13
Diluted EPS
-2.42-2.26-1.85-6-3.97-5.55-3.45-2.45-0.89
Data sourceData sourceData sourceData sourceData sourceData source